Generics Bulletin is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Beximco Profit Tumble Continues Amid Hostile Macro Climate

Company Continues To Deliver Revenue Growth Alongside Profit Decline

Executive Summary

Beximco faced another quarter of declining profits despite growing revenue, as external headwinds including increased production costs took their toll on the firm.

You may also be interested in...



The Generics Bulletin Top 50, Part Three: Final Firms Enjoy Mixed Fortunes

In the third part of this year’s Generics Bulletin Top 50, we look at how various increases and declines for companies at the bottom of our table have affected their positions in the ranking.

Beximco Faces Potentially Rough Ride In The Face Of Macroeconomic Headwinds

Following a year of impressive business developments, economic developments such as a depreciating local currency threaten to knock Beximco off-course.

Amneal Outlines Ambitions To Become Leading Affordable Medicines Supplier In US

While it currently sits in fourth place, Amneal’s co-CEO Chirag Patel has laid out ambitions for the firm to become the number one supplier of affordable medicines in the US.

Topics

Related Companies

Latest Headlines
See All
UsernamePublicRestriction

Register

GB152709

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel